InsidersTradesSigma
基于 3 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Discover the full record of transactions filed by Gowen Maxine, 董事. Officer active across 2 companies, notably Aclaris Therapeutics, Inc.. Aggregated, 5 disclosures have been published. Breakdown: 0 buy · 1 sell. Total volume traded: €24. Activity tracked since 10 August 2023. The latest transaction was filed on 10 August 2023 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 条申报中的 5 条
Maxine Gowen is a Board Member at Aclaris Therapeutics, Inc., a biopharmaceutical company focused on developing dermatological treatments. As a board member, she participates in overseeing the company's strategies and making key decisions. Maxine has extensive experience in the biopharmaceutical sector, providing valuable insights to the board.